Regulatory Affairs Archives

13 Feb 23

Briefing session for Regulatory Intelligence Survey

The Hong Kong Association of Pharmaceutical Industry organized a successful briefing session for its Regulatory Intelligence Survey, attracting over 50 members to join the event.

11 Nov 22

Asia Summit on Global Health 2022

Asia Summit on Global Health 2022 It is a great privilege for The Hong Kong Association of the Pharmaceutical Industry to join the Asia Summit on Global Health 2022 organized […]

28 Jun 22

Pharmaceutical Promotion: UMAO & related laws and regulations

To ensure members have a thorough understanding of the relevant laws, regulations and Codes regarding medicinal material communicating to the public via different mediums, the HKAPI organises an event with law enforcement authorities and experts to explain the law and its enforcement.

02 Jun 22

Tackling the Threat of Antimicrobial Resistance

The High-Level Steering Committee on Antimicrobial Resistance was set up in 2016 to call for collaboration, synergy and cross-fertilisation of all professional sectors under the "One Health" framework in response to AMR. Ms. Sabrina Chan, the Senior Executive Director of HKAPI has been a member of the Steering Committee since the establishment of the Committee.

25 Mar 22

Regulatory Training Workshop Series concluded successfully

The Regulatory Training Workshop Series held from February to March 2022 concluded successfully.

14 Jan 22

Webinar – Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong

Dr Daniel Lee of the Chinese University of Hong Kong, introduced the first ATP GMP facility in Hong Kong to our members.

14 Jan 21

GBA Training 2020

The Greater Bay Area development has taken centre stage in Hong Kong Policy Address 2020. To facilitate members taking business opportunities in GBA, HKAPI jointly organized a virtual training with the Shenzhen Hospital Manager Association in November and December 2020.

18 Dec 19

Briefing session for Regulatory Intelligence Survey

Asia Summit on Global Health 2022

Pharmaceutical Promotion: UMAO & related laws and regulations

Tackling the Threat of Antimicrobial Resistance

Regulatory Training Workshop Series concluded successfully

Webinar – Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong

GBA Training 2020

New Product Submission and Best Practice Workshop

Product Life Cycle Management from Regulatory Perspective and Best Practice Workshop

Drug Office-HKAPI Joint Briefing Session

© The Hong Kong Association of the Pharmaceutical Industry | 香港科研製藥聯會

All Right Reserved

Disclaimer

Privacy

Terms of Use